<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t9ukxkr8ps9e st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file • PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="HIV Teaching Manual: Comprehensive Guide for KMTC Module.pdf">HIV Teaching Manual: Comprehensive Guide for KMTC Module.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">1.7MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> HIV Teaching Manual: Comprehensive Guide for KMTC Module.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><img src="assets/images/image-20260202-d7e248a8.jpeg" alt="img-0.jpeg"></p>
<p>KENYA MEDICAL TRAINING COLLEGE</p>
<p>A TEACHING MANUAL FOR HIV, AIDS AND STI COMMON COLLEGE MODULE.</p>
<p>COMPILED BY
Faith Muthoki</p>
<p><img src="assets/images/image-20260202-8cd1bad4.jpeg" alt="img-1.jpeg"></p>
<p>2</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="preface">PREFACE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#preface" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>This manual is designed to conform to the curriculum of HIV/AIDS and STI common college module across all the departments. This module is taught across all the 19 departments for diploma students in year one semester one. currently in use at the Kenya Medical Training College with the aim of helping the student understand the concepts of HIV/AIDS transmission, management, and prevention in a simplified form.</p>
<p>The material is organized to give the learner not only theoretical knowledge but also provides practical procedures of skills application in HIV/AIDS management.</p>
<p>The information is sequenced in such a way that each new topic is a build-up from the previous one. In other words, the manual is organized in a stair-case approach.</p>
<p>Sample questions have been incorporated suitably within the manual to help the student in self-assessment.</p>
<p>It is envisaged that this manual will help build and shape the competencies required in the future by the learner.</p>
<p>MODULE 1: HIV, AIDS AND STIS</p>
<p>Code: 103
Hours: 30
Credit: 03</p>
<p>Introduction to HIV, AIDS AND STIS</p>
<p>This teaching manual for HIV, AIDS and STIs, contains relevant information required for training diploma students across all medical fields. HIV, AIDS and STIs are still a major problem of public health concern. Equipping health care workers with the necessary knowledge regarding HIV, AIDS and STIs will help communities in Kenya to curb the situation.</p>
<p>Module Competence</p>
<p>This module is designed to enable the learner to demonstrate understanding of HIV/AIDS and STIs in the community.</p>
<p>Module objectives</p>
<p>By the end of this module, the learners should be able to;</p>
<ol>
<li>Discuss the epidemiology of HIV/AIDS and STIs.</li>
<li>Describe the HIV prevention strategies at the community level.</li>
<li>Explain the concepts in management of HIV, AIDS and related disease in the community</li>
<li>Discuss social and behaviour change communication</li>
<li>Explain concepts and principles of HCBC in prevention and management of HIV, AIDS and related diseases.</li>
<li>Outline strategies in prevention and management of STIs.</li>
</ol>
<p>Module Outcomes</p>
<p>By the end of this module, the learner should:</p>
<ol>
<li>Demonstrate understanding of the epidemiology of HIV/AIDS and STIs.</li>
<li>Create awareness on HIV prevention strategies at the community level.</li>
<li>Explain the concepts in management of HIV, AIDS and related disease in the community</li>
</ol>
<p>3</p>
<ol start="4">
<li>Conduct social and behaviour change communication</li>
<li>Apply concepts and principles of HCBC in prevention and management of HIV, AIDS and related diseases.</li>
<li>Apply appropriate strategies in prevention and management of STIs.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="module-units">Module Units<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#module-units" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Unit Name</p>
<p>Hours</p>
<table><thead><tr><th></th><th>Theory</th><th>practical</th></tr></thead><tbody><tr><td>1. Fundamentals of HIV/AIDS and STIs</td><td>06</td><td>0</td></tr><tr><td>2. Prevention of HIV and AIDS</td><td>04</td><td>00</td></tr><tr><td>3. Management of HIV and AIDS</td><td>06</td><td>00</td></tr><tr><td>4. Social and behavior change communication (SBCC)</td><td>06</td><td>00</td></tr><tr><td>5. Home and community based care (HCBC)</td><td>04</td><td>00</td></tr><tr><td>6. STIs</td><td>04</td><td>00</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="module-contents">Module contents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#module-contents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>UNIT 1: FUNDAMENTALS OF HIV AND AIDS (8 Hours)</p>
<p>1.1: Definition of terms
1.1.1: HIV- An acronym</p>
<p>Human</p>
<p>Immunodeficiency</p>
<p>Virus</p>
<p>HIV attacks cells in the immune system (the body's natural defense against illness). The virus destroys a type of white blood cells in the immune system called T-helper cells also referred to as CD4 cells and uses this cells to make copies of itself. This weakens a person's immune system.</p>
<p>1.1.2: AIDS- An Acronym</p>
<p>Acquired</p>
<p>5</p>
<p>Immune</p>
<p>Deficiency</p>
<p>Syndrome</p>
<p>A set of symptoms and illnesses that develop when advanced HIV infection has destroyed the immune system.</p>
<p>If HIV is left untreated, it may take up to 10-15 years for the immune system to be so severely damaged that it can no longer defend itself. However, the rate at which HIV progresses to AIDS varies depending on age, general health and background. Fewer people develop AIDS now days as more people are on treatment.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-2-history-of-hiv-aids">1.2: History of HIV/AIDS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-2-history-of-hiv-aids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>HIV is believed to have originated from Kinshasa in DRC around 1920 when HIV crossed species from chimpanzees to humans.</p>
<p>Available data suggests that current epidemics started in the mid- late 1970s.</p>
<p>By 1980s HIV had already spread to North America, South America, Europe, Africa and Australia.</p>
<p>1981</p>
<p>In 1981, cases of a rare lung infection called Pneumocystis carinii pneumonia (PCP) were found in five young, previously healthy gay men in Los Angeles.</p>
<p>At the same time, there were reports of a group of men in New York and California with an unusually aggressive cancer named Kaposi’s Sarcoma.</p>
<p>In December 1981, the first cases of PCP were reported in people who inject drugs.</p>
<p>By the end of the year, there were 270 reported cases of severe immune deficiency among gay men - 121 of them had died.</p>
<p>1982</p>
<p>In June 1982, a group of cases among gay men in Southern California suggested that the cause of the immune deficiency was sexual and the syndrome was initially called gay-related immune deficiency (or GRID).</p>
<p>Later that month, the disease was reported in haemophiliacs and Haitians leading many to believe it had originated in Haiti.</p>
<p>In September, the CDC used the term 'AIDS' (acquired immune deficiency syndrome) for the first time.</p>
<p>AIDS cases were also being reported in a number of European countries.</p>
<p>In Uganda, doctors reported cases of a new, fatal wasting disease locally known as 'slim'.</p>
<p>By this point, a number of AIDS-specific organizations had been set up including the San Francisco AIDS Foundation (SFAF) in the USA and the Terrence Higgins Trust in the UK.</p>
<p>1983</p>
<p>In 1983, AIDS was reported among the female partners of men who had the disease suggesting it could be passed on via heterosexual sex.</p>
<p>The first reports of AIDS in children hinted that it could be passed via casual contact but this was later ruled out and it was concluded that they had probably directly acquired AIDS from their mothers before, during or shortly after birth.</p>
<p>The CDC identified all major routes of transmission and ruled out transmission by casual contact, food, water, air or surfaces.</p>
<p>The CDC also published their first set of recommended precautions for healthcare workers and allied health professionals to prevent AIDS transmission.</p>
<p>The World Health Organization (WHO) held its first meeting to assess the global AIDS situation and began international surveillance.</p>
<p>6</p>
<p>1984</p>
<p>In 1984, the National Cancer Institute announced they had found the cause of AIDS, the retrovirus HTLV-III. In a joint conference with the Pasteur Institute they announced that LAV and HTLV-III are identical and the likely cause of AIDS. A blood test was created to screen for the virus with the hope that a vaccine would be developed in two years.</p>
<p>1985</p>
<p>In 1985, the U.S. Food and Drug Administration (FDA) licensed the first commercial blood test, ELISA, to detect antibodies to the virus. Blood banks began to screen the USA blood supply.</p>
<p>In December, the U.S. Public Health Service issued the first recommendations for preventing mother to child transmission of the virus.</p>
<p>1986</p>
<p>In May 1986, the International Committee on the Taxonomy of Viruses said that the virus that causes AIDS will officially be called HIV (human immunodeficiency virus) instead of HTLV-III/LAV.</p>
<p>1.3: Etiology</p>
<p>Caused by a virus (Lent virus), this virus is said to cause disease in both animals and humans.</p>
<p>1.4: Epidemiology of HIV/AIDS</p>
<p>In East Africa, Uganda was the first state in the region to declare HIV cases in 1982 followed by Kenya in 1984 and Tanzania in 1985.</p>
<p>HIV is termed as a global pandemic.</p>
<p>It is a major public health issue claiming 33 million deaths.</p>
<p>Globally, 38 million people living with HIV by 2019</p>
<p>With increased access to effective HIV prevention, diagnosis, treatment and care including opportunistic infections, HIV has become a manageable chronic health condition enabling people living with HIV to lead long and healthy lives.</p>
<p>By 2019, 68% of adults and 53% of children living with HIV globally were receiving ART.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="kenya">Kenya<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#kenya" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Kenya has the joint third-largest epidemic in the world, alongside Mozambique and Uganda.</p>
<p>Kenya’s HIV epidemic affects most of its general population, but groups of men who have sex with men, women, sex workers and people who inject drugs are still more vulnerable to infection.</p>
<p>In recent decades Kenya has been a huge prevention success story in the region. As a result new infections have fallen dramatically in recent years.</p>
<p>Although awareness of HIV and AIDS is high in Kenya, many people living with HIV face high levels of stigma and discrimination which prevent people accessing HIV services.</p>
<p>By 2019, 1.5 m people living with HIV</p>
<p>Prevalence of 4.5% (ages 15-49 years)</p>
<p>42,000 new HIV infections</p>
<p>21,000 AIDS related death</p>
<p>75% adults on ART</p>
<p>63% children on ART</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-5-mechanism-of-transmission">1.5: Mechanism of transmission<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-5-mechanism-of-transmission" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The HIV virus is present in blood, semen, vaginal fluids, and breast milk.</p>
<p>8</p>
<p>Major mode of transmission include;</p>
<ul>
<li>Sexual intercourse 80-90%</li>
<li>Contact with infected blood through blood transfusion, tattooing, circumcision and people who inject drugs.</li>
<li>Mother to child transmission- through labour, delivery, or breastfeeding.</li>
</ul>
<p>1.6: HIV types and subtypes</p>
<p>1.6.1: There are two types of HIV virus</p>
<ul>
<li>HIV 1- Most common, it accounts for around 95% of all infections worldwide.</li>
<li>HIV type2- Common in West Africa, less infectious and progresses slowly than HIV1 and causes fewer deaths.</li>
</ul>
<p>1.6.2: Subtypes of HIV-1</p>
<p>HIV 1 is divided into 4 groups; M, N, O and P. Group M is responsible for more than 90% of HIV/AIDS cases deriving from infection with HIV-1.</p>
<p>Group M is also divided into nine distinct subtypes; A, B, C, D, F, G, H, J and K. Globally, almost half of all HIV-1 infections are of subtype C (47%). Subtypes B and A are responsible for 12% and 10% of infections, respectively.</p>
<p>1.7: Key risk factors</p>
<ol>
<li>Present or past high risk behavior:</li>
</ol>
<ul>
<li>Having unprotected anal or vaginal sex</li>
<li>Multiple sexual partners.</li>
<li>Sexual partners with high risk behavior.</li>
<li>Homosexuals.</li>
<li>Drug and substance abuse.</li>
</ul>
<ol start="2">
<li>
<p>Recent history of genitourinary diseases (GUD) or any other sexually transmitted infections (STI)</p>
</li>
<li>
<p>History of blood transfusion especially if not screened.</p>
</li>
</ol>
<p>9</p>
<ol start="4">
<li>History of any surgical operation or procedures which could have involved use of unsterilized instruments (tattooing, ear piecing, circumcision).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1-8-hiv-viral-replication-cycle">1.8 HIV viral replication cycle<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-8-hiv-viral-replication-cycle" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>To understand each stage in the HIV life cycle, it is important for us to first imagine what HIV virus looks like.</p>
<p>The seven stages of the HIV-01 virus infection</p>
<ol>
<li>
<p>Binding: The virus attaches itself to the cell surface of the host cell (target CD4 cell).</p>
</li>
<li>
<p>Fusion: Outer envelope is removed to release the RNA of the virus into the cytoplasm of the host cell.</p>
</li>
<li>
<p>Reverse transcription: Reverse transcriptase enzyme convert viral RNA into DNA</p>
</li>
<li>
<p>Integration: Viral DNA penetrates T-cell nucleus and integrate into host cell chromosome by the help of the enzyme integrase.</p>
</li>
<li>
<p>Replication: Viral DNA commands chromosome to make more viral DNA.</p>
</li>
<li>
<p>Assembly: Viral nucleic acid and protein structural substances assemble into capsome and then releases them into capsids to enclose the viral nucleic mediated by the enzyme protease.</p>
</li>
<li>
<p>Budding: The new virus eventually kills the swollen host cell which then releases it into the blood stream</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-8-progression-of-hiv-disease">1.8: Progression of HIV disease<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-8-progression-of-hiv-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>HIV virus invades CD4+ T cells resulting in a decline in CD4+ T cell numbers below the critical level, and loss of cell-mediated immunity – therefore, the body becomes progressively more susceptible to opportunistic infections and cancer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="who-staging">WHO STAGING<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#who-staging" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="stage-1">Stage 1<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stage-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Asymptomatic</li>
<li>Persistent generalized lymphadenopathy</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="stage-2">Stage 2<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stage-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Moderate unexplained weight loss &lt; 10% of body weight</li>
<li>Recurrent respiratory tract infections (sinusitis, tonsillitis, otitis media, pharyngitis).</li>
<li>Recurrent skin diseases (herpes zoster, Angular cheilitis, Papular pruritic eruption, Fungal nail infections and Seborrhoeic dermatitis)</li>
<li>Recurrent oral ulceration</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="stage-3">Stage 3<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stage-3" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Unexplained severe weight loss (&gt;10% of presumed or measured body weight)</li>
<li>Unexplained chronic diarrhoea for longer than 1 month</li>
<li>Unexplained persistent fever (intermittent or constant for longer than 1 month)</li>
<li>Persistent oral candidiasis</li>
<li>Pulmonary tuberculosis</li>
</ul>
<p>11</p>
<p>Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia)
Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis
Unexplained anaemia</p>
<p>Stage 4
HIV wasting syndrome
Severe OIs set in</p>
<p>1.9: Most at risk populations (MARPS)
Men who have sex with men
Women
Female sex workers
People who inject drugs</p>
<p>1.10: Myths and misconceptions</p>
<p>Therefore there is need for everyone to know how HIV/AIDS is and is not transmitted to reduce high risk behaviors and avoid unnecessary fears and stigmatization.</p>
<p>HIV cannot be spread through touch, tears, sweat, saliva, or stool</p>
<p>HIV cannot be transmitted through:</p>
<ul>
<li>Breathing the same air</li>
<li>Touching a toilet seat or door handle</li>
<li>Drinking from a water fountain</li>
<li>Casual contact- Hugging, kissing, or shaking hands</li>
<li>Sharing eating utensils</li>
<li>Using exercise equipment at a gym</li>
<li>Coughing</li>
<li>Insect bite e.g. mosquitoes</li>
</ul>
<p>12</p>
<p>1.11: Opportunistic infections</p>
<p>Opportunistic infections (OIs) are illnesses that occur more frequently and are more severe in people with HIV. This is because they have damaged immune systems.</p>
<p>But some people with HIV still develop OIs because</p>
<ul>
<li>They may not know they have HIV</li>
<li>They may not be on HIV treatment</li>
<li>Their HIV treatment may not be working properly</li>
</ul>
<p>The common opportunistic infections related to HIV/AIDS includes;</p>
<p>Encephalopathy, HIV-related- This brain disorder can occur as part of acute HIV infection or can result from chronic HIV infection. Its exact cause is unknown, but it is thought to be related to infection of the brain with HIV and the resulting inflammation.</p>
<p>Herpes simplex virus (HSV) - HSV is a common virus that causes no major problems for most people. HSV is usually acquired sexually or passed from mother-to-child during birth. In most people with healthy immune systems, HSV is usually latent (inactive). Stress, trauma, other infections, or suppression of the immune system, (such as by HIV), can reactivate the latent virus and symptoms can return. HSV can cause painful cold sores (sometime called fever blisters) in or around the mouth, or painful ulcers on or around the genitals or anus.</p>
<p>Cancers</p>
<ul>
<li>Kaposi’s sarcoma- Is caused by a virus called Kaposi’s sarcoma herpes virus (KSHV) or human herpes virus 8 (HHV-8). Kaposi’s sarcoma causes small blood vessels to grow abnormally and can occur anywhere in the body. Kaposi’s sarcoma appears as firm pink or purple spots on the skin that can be raised or flat. Kaposi’s sarcoma can be life-threatening when it affects organs inside the body, such as the lung, lymph nodes, or intestines.</li>
<li>Cervical cancer- Cervical cancer starts within the cervix (the lower part of the uterus at the top of the vagina) and spreads (becomes invasive) to other parts of the body. Cervical</li>
</ul>
<p>13</p>
<p>cancer can be prevented by having your health care provider perform regular examinations of the cervix</p>
<p>Lymphoma- Lymphoma refers to cancer of the lymph nodes and other lymphoid tissues in the body. There are many kinds of lymphomas. Some types, such as non-Hodgkin lymphoma and Hodgkin lymphoma, are associated with HIV.</p>
<p>Tuberculosis (TB) - TB is caused by a bacterium called Mycobacterium tuberculosis. TB spreads through the air when a person with TB coughs, sneezes, or speaks. Breathing in the bacteria can lead to infection in the lungs. Symptoms of TB in the lungs include cough, tiredness, weight loss, fever, and night sweats.</p>
<ul>
<li>Defaulter tracing process in TB</li>
<li>Identifying the patient</li>
<li>Getting details from the CHEW or the health facility on the following (Name, Age, Sex, TB patient's number, the time when the patient started treatment, Physical address and land mark, Telephone number for patient and treatment supporters, Trace the patient using the physical address provided).</li>
<li>Provide health education and counsel the patient traced on the importance of adherence to TB treatment</li>
<li>Refer the traced patient to the CHEW</li>
<li>Obtain feedback from the CHEW on the patient</li>
</ul>
<p>Pneumocystis pneumonia (PCP-PCP) is a lung infection caused by the fungus Pneumocystis jirovecii. PCP occurs in people with weakened immune systems. The first signs of infection are difficulty breathing, high fever, and dry cough.</p>
<p>Candidiasis-Candidiasis is caused by infection with a fungus called Candida. Candidiasis can affect the skin, nails, and mucous membranes throughout the body. People with HIV often have trouble with Candida, especially in the mouth and vagina. Candidiasis is only considered an OI when it causes severe or persistent infections in the mouth or vagina, or when it develops in the esophagus (swallowing tube) or lower respiratory tract, such as the trachea and bronchi (breathing tube), or deeper lung tissue.</p>
<p>14</p>
<p>Cryptococcosis- This illness is caused by infection with the fungus Cryptococcus neoformans. The fungus typically enters the body through the lungs and can cause pneumonia. Cryptococcosis usually affects the lungs or the central nervous system (the brain and spinal cord), but it can also affect other parts of the body.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-12-hiv-counseling-and-testing">1.12: HIV counseling and testing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-12-hiv-counseling-and-testing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1-12-1-types-of-hiv-counseling-and-testing">1.12.1: Types of HIV counseling and testing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-12-1-types-of-hiv-counseling-and-testing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Provider initiated counseling and testing (PICT) - Provider-initiated HIV counselling and testing (PICT) is routinely offered by healthcare providers to persons attending healthcare facilities as a standard component of medical care. PICT should be offered to all persons attending clinical services in both the public and private sector. Healthcare providers should recommend HTS to all patients in a health facility, regardless of whether they show signs or symptoms of HIV infection. This allows the healthcare provider to make medical decisions that would not be possible without knowledge of the patient's HIV status. Additionally, PICT contributes to increased rates of HIV testing and early identification of HIV-infected persons, who may not otherwise know their HIV status.</li>
<li>Client- initiated counseling and testing (CICT/VCT) - Client-initiated counselling and testing (also referred to as voluntary counselling and testing [VCT]) refers to when HTS is provided within healthcare facilities for clients who present specifically for these services. Clients may voluntarily decide to learn their HIV status as an individual, couple or family.</li>
<li>Routine testing and counseling</li>
<li>Required testing</li>
<li>Testing for blood and tissue donation</li>
<li>Testing for medical research and surveillance Components of HIV testing</li>
</ol>
<p>15</p>
<p>1.12.2: 5Cs of HIV counseling and testing</p>
<ol>
<li>Informed Consent</li>
<li>Confidentiality</li>
<li>Counselling</li>
<li>Correct test results</li>
<li>Connection (linkage to care, treatment and other services)</li>
<li>Informed consent</li>
</ol>
<p>Informed consent refers to a person being given relevant and appropriate information about an HIV test, and based on that information, given an opportunity to either accept or refuse to do the HIV test. Informed consent should always be in written form and signed by only the client or proxy and the healthcare provider to avoid unintended disclosure of results.</p>
<p>The information that clients and patients require in order to give their informed consent may vary based on the service delivery approach and setting, but should generally include information about:</p>
<ul>
<li>Benefits and implications of knowing one’s status and reasons for recommending HIV testing services</li>
<li>Client’s right to withdraw consent at any stage of the process</li>
<li>Availability of follow-up treatment; care and support; and prevention services</li>
<li>Importance of disclosure and partner/family testing and availability of couple HIV testing services</li>
<li>HIV testing services process and procedures</li>
</ul>
<p>Potential clients or patients should:</p>
<ul>
<li>understand why they are being tested</li>
<li>understand and report on the consequences of a negative or positive test result</li>
<li>report how they are likely to respond to either result</li>
</ul>
<p>16</p>
<p>Informed consent should always be documented in the following settings and populations:</p>
<ul>
<li>Infants and children: HIV testing services should be offered to the guardians or parents as applicable, and they should provide written informed consent. Where appropriate, children may also provide consent.</li>
<li>Couples: Informed consent should be given by individuals who are willing to be tested as a couple.</li>
<li>Research settings: Informed consent within clinical trials and other research settings should always be written and documented as stipulated by the national Department of Health’s Guidelines for Good Practice in Conduct of Clinical Trials with Human Participants 2006.</li>
<li>Illiteracy or inability to write: If the client cannot write, or has a disability that hinders his or her ability to write, the right-hand thumbprint can be used instead of the signature, if the client wishes to take up the HIV test and give signed consent.</li>
<li>Inability to make a decision: According to the National Health Act, if a client is unable to give informed consent, for example, in the case of unconsciousness/incapacitation or cognitive disability, and if the test is clinically indicated, such consent can be given by a person authorized to give such consent, in terms of any law or court order. In the case of adults, the spouse, next-of-kin (parent, grandparent, an adult child or a sibling of the person), clinician or clinical manager, in the specific order listed, can give informed consent.</li>
</ul>
<ol start="2">
<li>
<p>Confidentiality: Discussions between the HTS provider and the client should not be disclosed to anyone without the expressed consent of the person being tested. Shared confidentiality with a partner or family members or trusted others must be encouraged.</p>
</li>
<li>
<p>Counselling: Pre-test information can be done in a group setting, but a private setting must be provided for individuals who have questions that they do not wish to share with others. HIV testing must be followed by appropriate high quality post-test counselling.</p>
</li>
</ol>
<p>The pre-test information session</p>
<p>17</p>
<p>The pre-test information session to an individual or to a group must include clear information on:</p>
<ul>
<li>The benefits of HIV testing</li>
<li>The meaning of an HIV-positive and an HIV-negative diagnosis</li>
<li>Services - including ART provision - that are available should the client test positive</li>
<li>The potential for incorrect results if a person who is already on ART is tested</li>
<li>A brief description of prevention options and encouragement of partner testing</li>
<li>The confidentiality of the test result and any other information shared by the client</li>
<li>The right to refuse to be tested and that declining testing will not affect the client's access to HIV services or general medical care</li>
<li>Potential risks of testing, particularly in instances where there are legal implications for those who test positive and for those whose sexual or other behaviour is stigmatized</li>
</ul>
<p>Post-test services for people testing HIV-negative</p>
<p>Those testing HIV-negative should receive health information about their test results. The health information should include;</p>
<p>Risk reduction counselling and recommendations on uptake of preventive behaviours including consistent condom use.</p>
<p>The post-test counselling session should focus on keeping the individual negative. Active linkage to appropriate services is strongly recommended.</p>
<p>In sero-discordant relationships, counselling for those who test HIV-negative should include education on methods and behaviours to prevent HIV acquisition and the provision of male or female condoms, lubricants and guidance on their use.</p>
<p>Services for people with discrepant test results</p>
<p>18</p>
<p>An HIV-inconclusive/indeterminate result means that the first reactive test results were not confirmed by subsequent testing using an HIV rapid test (screening test was reactive and confirmatory test was nonreactive). Clients with an HIV-inconclusive status should be told that a definitive diagnosis cannot be provided that day and that immediate referral to HIV care or ART initiation is not appropriate. Whole blood should be drawn and sent to the laboratory for ELISA testing as a tie breaker. Clients should be given a clear plan for follow-up testing. All clients with an HIV-inconclusive result should be encouraged to return within seven days for their ELISA results to confirm their diagnosis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="services-for-people-testing-hiv-positive">Services for people testing HIV-positive<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#services-for-people-testing-hiv-positive" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>People who test HIV-positive should receive health information about their test results. It is essential to ensure that the HIV status test results are correct. All post-test counselling should be client-centred and responsive to and tailored to the unique situation of each individual or couple. Health workers, professional counsellors, social workers and trained lay providers can provide relevant counselling.</p>
<p>The post-test counselling information must include:</p>
<ul>
<li>An explanation of the test results and diagnosis</li>
<li>Clear information on ART and its benefits</li>
<li>Where and how to obtain ART</li>
<li>Make an active referral for a specific time and date</li>
<li>How to prevent transmission of HIV and viral suppression condoms and lubricants and guidance on their use</li>
<li>How to encourage and offer HIV testing to sexual partners, children and other family members of the client. This can be done individually, through couples testing, index testing or partner notification</li>
</ul>
<ol start="4">
<li>
<p>Correct test results: Quality assurance (QA) mechanisms are essential to ensure that people receive a correct diagnosis.</p>
</li>
<li>
<p>Connection: Linkage to prevention, treatment and care services and effective and appropriate follow-up should be provided.</p>
</li>
</ol>
<p>19</p>
<p>1.12.3: Components of HIV testing protocol</p>
<p>Component: 1 Assess need for testing</p>
<p>During this component, you will:</p>
<ul>
<li>Introduce yourself to the client and describe your role as counselor</li>
<li>Address the relation between the diseases that the patient has with HIV Sample text (individual adults):</li>
<li>In addition to what has been discussed with you about your current condition, I wish to discuss with you about issues to do with HIV/AIDS</li>
<li>It is important for you to know that almost any medical condition may be associated with HIV infection</li>
<li>For us to understand the primary cause of your illness and look after you better, it is advisable for you to undertake an HIV test.</li>
<li>The only sure way of knowing whether or not you have the HIV virus is through a simple blood test which I advise we do today.</li>
</ul>
<p>Component: 2 Benefits of taking a HIV test</p>
<p>During this component, you will:</p>
<ul>
<li>Explain the benefits to the patient of taking a HIV test</li>
<li>Implications of HIV test results</li>
<li>If negative or if positive</li>
<li>Explain the HIV testing process</li>
<li>Offer the test</li>
</ul>
<p>Benefits of knowing ones HIV status include prevention of HIV infection, treatment and prevention of HIV related opportunistic infections, life- prolonging ARV drugs, access to emotional and social support.</p>
<p>The test could turn either positive or negative. If the result is negative you will be able to;</p>
<p>20</p>
<ul>
<li>Plan for the future</li>
<li>Plan to reduce risky behavior if any</li>
<li>Reduce your anxiety about past exposure</li>
</ul>
<p>The test may turn positive. If so, apart from treating the present condition, we will offer you a wide range of services such as treatment and prevention of other HIV related infections. In addition, you will be able to;</p>
<ul>
<li>Plan for the future</li>
<li>Access PMTCT services</li>
<li>Access nutrition education</li>
<li>Plan behavior change to reduce risk</li>
<li>Access psychological and social support</li>
<li>Learn about positive living</li>
</ul>
<p>Remember that you are completely within your right to decline the HIV test. This has no bearing whatsoever to our commitment to treat you for any other diseases or condition that you may have.</p>
<p>Component: 3 HIV testing</p>
<p>During this component, you will:</p>
<ul>
<li>Conduct the test or show the patient where they need to go for testing</li>
</ul>
<p>Component: 4 Posttest counseling</p>
<p>During this component, you will:</p>
<ul>
<li>Communicate and show the HIV test results to patient</li>
<li>Explain appropriate follow up steps Sample text (individual adults):</li>
</ul>
<p>If Negative, The test result is negative, which means you have not been infected with HIV. This result does not tell us about the exposure that occurred (specify) most recently.</p>
<p>You may want to consider another test in and/or encourage your partner to come in and be tested. As we talked about earlier, we will continue to treat you for your current illness. It is recommended that you visit a VCT Centre for more counseling on how to protect yourself better from HIV.</p>
<p>If Positive, The test result is positive; this indicates that you are infected with HIV. It is important to note that one can live for a long time with the virus even if they have had some illnesses like the one you have. Now that we know that you have the virus we can manage you</p>
<p>21</p>
<p>better. We will first treat you for your current illness then refer you to the comprehensive care Centre for a further management including management of HIV.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="unit-2-prevention-of-hiv-and-aids-6-hours">UNIT 2: PREVENTION OF HIV AND AIDS (6 Hours)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#unit-2-prevention-of-hiv-and-aids-6-hours" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="2-1-abc">2.1: ABC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-1-abc" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>Abstinence – Avoid premarital sex</strong></p>
<p>Behaviour change – The major route of HIV transmission of through sex and in order to reduce the risk of transmission is by correct use of condom every time you have sex, limiting number of sexual partners and being faithful to your sexual partner.</p>
<p>Use of condom - Correct and consistent use of male and female condoms during vaginal or anal penetration can protect against the spread of STIs, including HIV. Evidence shows that male latex condoms when used consistently have an 85% or greater protective effect against HIV and other STIs.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="2-2-voluntary-male-medical-circumcision-vmmc">2.2: Voluntary male medical circumcision (VMMC)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-2-voluntary-male-medical-circumcision-vmmc" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Medical circulation reduces the risk of heterosexually acquired HIV infection in men by approximately 50% including in ‘real world’ settings where scale up occurred alongside the increasing coverage of ART with its secondary prevention effect. In 2020, WHO updated the 2007 recommendation for VMMC to continue as an additional prevention intervention among males age 15 years and older</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="2-3-drugs">2.3: Drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-3-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Use of ARVs for prevention - Secondary prevention benefits of ART. Several studies confirmed that if an HIV-positive person is taking ART and is virally suppressed they do not transmit HIV to their uninfected sexual partners WHO recommended that all people living with HIV should be offered ART with the main aim of saving lives and contributing to reducing HIV transmission.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="2-3-1-pre-exposure-prophylaxis">2.3.1: Pre-exposure prophylaxis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-3-1-pre-exposure-prophylaxis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>WHO recommends PrEP as a prevention choice for HIV negative people who are at substantial risk of HIV infection as part of a combination of prevention approaches. The key target populations, including sero-discordant heterosexual couples (where one partner is infected and</p>
<p>22</p>
<p>the other is not), men who have sex with men, transgender women, high-risk heterosexual couples (sex workers), and people who inject drugs. PrEP is highly effective if taken consistently and correctly, it is safe and reduces one's risk of acquiring HIV by over 90%.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="2-3-2-post-exposure-prophylaxis">2.3.2 Post exposure prophylaxis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-3-2-post-exposure-prophylaxis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>PEP is the use of ARVs within 72 hours of exposure to HIV to prevent infection. PEP includes counselling, first aid care, HIV testing, and administration of a 28-day course of ARV drugs with follow-up care. WHO recommends PEP use for both occupational and non-occupational exposures, and for adults and children.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="2-4-elimination-of-mother-to-child-transmission-emtct">2.4 Elimination of mother to child transmission (eMTCT)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-4-elimination-of-mother-to-child-transmission-emtct" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>The transmission of HIV from an HIV-positive mother to her child during pregnancy, labour, delivery or breastfeeding is called vertical or mother-to-child transmission (MTCT). In the absence of any interventions during these stages, rates of HIV transmission from mother-to-child can be between 15% and 45%. The risk of MTCT can almost be eliminated if both the mother and her baby are provided with ARV drugs as early as possible in pregnancy and during the period of breastfeeding.</p>
<p>23</p>
<p>UNIT 3: MANAGEMENT OF HIV AND AIDS (10 Hours)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-1-anti-retroviral-therapy-art">3.1: Anti-retroviral therapy (ART)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-1-anti-retroviral-therapy-art" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-1-1-goal-of-art">3.1.1: Goal of ART<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-1-1-goal-of-art" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>The main goal of ART is to suppress viral replication with the aim of reducing the patient's VL to undetectable levels. Uninterrupted ART with ongoing strict adherence will help maintain undetectable VL levels thereby; Preventing damage to the body's immune system, restoring, maintaining healthy living and educing the risk of sexual and vertical transmission of HIV.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="other-goals-of-art-therapy">Other goals of art therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-goals-of-art-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ol>
<li>To maintain maximal suppression of the viral load (i.e., fewer than 50 copies per mL).</li>
<li>Restore or preserve immunity/immunologic function.</li>
<li>Improve quality of life of PLWHA</li>
<li>Reduce HIV-related morbidity and mortality.</li>
<li>Prevent HIV transmission- sexual and vertical transmission of HIV</li>
</ol>
<p>Effective ART consists of a minimum of 3 agents from at least 2 different classes of ARV</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-1-2-eligibility-criteria">3.1.2: Eligibility criteria<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-1-2-eligibility-criteria" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>All individuals with confirmed HIV infection are eligible for ART, irrespective of CD4 cell levels, WHO clinical stage, age, pregnancy or breastfeeding status, co-infection status, risk group, or any other criteria.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-1-3-timing-of-art-initiation">3.1.3: Timing of ART initiation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-1-3-timing-of-art-initiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>ART should be started in all patients as soon as possible (preferably within 2 weeks of confirmation of HIV status). ART can be initiated as soon as patients meet the ART Readiness Criteria. Even if it is the same day as enrolment into care. ART initiation on the same day as enrolment into care has additional benefits for HIV prevention (e.g. for pregnant and breastfeeding women, and the HIV positive partner in a discordant relationship), and may have additional mortality benefits for infants less than 12 months of age.</p>
<p>24</p>
<p>Special Considerations for Timing of ART Initiation</p>
<p>Enhanced Adherence Counselling Sessions: Overview and Timing of ART Initiation</p>
<p>Pregnant and breastfeeding- Consider ART initiation on the same day as enrolment. Intensive adherence counselling and close follow-up required because of limited time for patient preparation</p>
<p>Infants &lt; 12 months- Consider ART initiation on the same day as enrolment. Intensive adherence counselling and close follow-up required because of limited time for patient preparation.</p>
<p>Patients with strong motivation to start ART immediately- Consider ART initiation as soon as they meet ART Readiness Assessment criteria, even if on the same day as enrolment. Intensive adherence counselling and close follow-up required because of limited time for patient preparation. Patients with newly diagnosed TB- Defer ART until tolerating anti-TB medication; initiate ART within 8 weeks of starting TB treatment (preferably within 2 weeks). Monitor closely for IRIS. Patients with cryptococcal meningitis- If treating CM with amphotericin and fluconazole: defer ART until after completing 4 weeks of CM treatment and symptoms have resolved. If treating CM with fluconazole alone: defer ART until after completing 4-6 weeks of CM treatment and symptoms have resolved. Monitor closely for IRIS</p>
<p>Patients for whom adherence will be particularly challenging- Start ART as soon as adequate support systems are in place for adherence (e.g. enrolling a PWIDs into a methadone program; psychiatric treatment for a patient with mental illness; caregiver identified for an orphan). A case manager should be assigned to all patients with complex adherence challenges.</p>
<p>All other patients- Start ART within 2 weeks of HIV diagnosis, once they meet ART Readiness Assessment criteria. Adequate ART preparation, and continued adherence monitoring and support is recommended after ART initiation for all patients</p>
<p>3.1.4: Classes of ARV drugs</p>
<ol>
<li>Nucleoside/nucleotide reverse transcriptase inhibitors</li>
</ol>
<p>25</p>
<p>They resulting in termination of the growing viral DNA chain. Chain termination can occur during RNA-dependent DNA or DNA-dependent DNA synthesis, inhibiting production of either the (−) or (+) strands of the HIV-1 proviral DNA.</p>
<p>Examples</p>
<p>Abacavir (ABC) 300 mg twice daily or 600 mg once daily</p>
<p>Emtricitabine (FTC) 200 mg once daily Lamivudine (3TC) 150 mg twice daily or 300 mg once daily Zidovudine (AZT) 300 mg twice daily</p>
<p>Tenofovir disoproxil fumarate (TDF) 300 mg once daily</p>
<p>Tenofovir alfenamide (TAF) 10-25 mg once daily</p>
<ol start="2">
<li>Non-nucleoside reverse transcriptase inhibitors (NNRTI)</li>
</ol>
<p>NNRTIs inhibit HIV-1 RT by binding and inducing the formation of a hydrophobic pocket proximal to, but not overlapping the active site. The binding of NNRTIs changes the spatial conformation of the substrate-binding site and reduces polymerase activity. The resistance generally results from amino acid substitutions such as L100, K101, K103, E138, V179, Y181, and Y188 in the NNRTI-binding pocket of RT</p>
<p>Efavirenz (EFV) 400–600 mg once daily</p>
<p>Etravirine (ETV) 200 mg twice daily</p>
<p>Nevirapine (NVP) 200 mg once daily for 14 days followed by 200 mg twice daily</p>
<ol start="3">
<li>Integrase inhibitors</li>
</ol>
<p>All integrase inhibitors in development target the strand transfer reaction and are thus referred to as either INIs or more specifically, integrase strand transfer inhibitors (InSTIs).</p>
<p>The selective effect on strand transfer is a result of a now well-defined mechanism of action in which the inhibitor;</p>
<p>(1) Binds only to the specific complex between integrase and the viral DNA an
(2) Interacts with the two essential magnesium metal ion cofactors in the integrase active site and also the DNA.</p>
<p>26</p>
<p>Therefore, all InSTIs are comprised of two essential components: a metal-binding pharmacophore, which sequesters the active site magnesiums, and a hydrophobic group, which interacts with the viral DNA as well as the enzyme in the complex.</p>
<p>InSTIs are therefore the only ARV class that interacts with two essential elements of the virus, the integrase enzyme as well as the viral DNA, which is the substrate for integration. Examples</p>
<ul>
<li>Dolutegravir (DTG) 50 mg once daily</li>
<li>Raltegravir (RAL) 400 mg twice daily</li>
</ul>
<p>Considerations for individuals receiving TB therapy In the presence of rifampicin, adjusted dose of DTG (50 mg twice daily) and RAL (800 mg twice daily), with close monitoring. In the presence of rifabutin or rifapentine, no dose adjustment is required.</p>
<ol start="4">
<li>Protease inhibitors</li>
</ol>
<p>The HIV-1 protease is the enzyme responsible for the cleavage of the viral gag and gag-pol polyprotein precursors during virion maturation. Examples</p>
<ul>
<li>Atazanavir/ritonavir (ATV/r) 300 mg/100 mg once daily</li>
<li>Darunavir + ritonavir (DRV/r) 800 mg + 100 mg once daily or 600 mg + 100 mg twice daily</li>
<li>Lopinavir/ritonavir (LPV/r) 400 mg/100 mg twice daily</li>
</ul>
<p>Considerations for individuals receiving TB therapy In the presence of rifampicin, adjusted dose of LPV/r (“Double dose” LPV 800 mg/ + ritonavir 200 mg twice daily or “super boosted” with LPV 400 mg/ + ritonavir 100 mg twice daily plus additional doses of RTV 300 mg twice daily), with close monitoring. In the presence of rifabutin, no dose adjustment required. Rifapentine should not be used.</p>
<ol start="5">
<li>
<p>Binding inhibitors- They target the receptor cells. Target receptors in glycoprotein gp120</p>
</li>
<li>
<p>Fusion inhibitors- Peptide fusion inhibitors were designed based on the discovery that two homologous domains in the viral gp41 protein must interact with each other to promote fusion, and that mimicry of one of these domains by a heterologous protein can bind and disrupt the intramolecular interactions of the virus protein.</p>
</li>
</ol>
<p>3.1.5: Monitoring and Changing ART</p>
<p>The objectives of clinical and laboratory monitoring during ART are to;</p>
<p>27</p>
<p>Identify and treat inter-current illnesses
Assess for and manage adverse drug reactions
Evaluate response to treatment.</p>
<p>3.1.6: Indications for changing ART include</p>
<ul>
<li>Adverse drug reactions (ADRs) or toxicity</li>
<li>Drug-drug interactions</li>
<li>Co-morbidity</li>
<li>Treatment failure</li>
</ul>
<p>3.1.7: Common side effects for ARVs</p>
<ul>
<li>Skins rash-Nevirapine</li>
<li>CNS symptoms (somnolence, insomnia, abnormal dreams, confusion, hallucination, amnesia)- Efavirenz</li>
<li>GI- Nausea, vomiting and diarrhea</li>
<li>Depression</li>
<li>Headache</li>
<li>Liver disease</li>
<li>Spontaneous bleeding</li>
<li>Bone marrow suppression- anaemia</li>
<li>Pancreatitis</li>
<li>Lacto acidosis</li>
<li>Fatigue</li>
<li>Peripheral neuropathy</li>
</ul>
<p>3.2: Nutrition</p>
<p>3.2.1: Goal of nutrition</p>
<p>Good nutrition is a critical component of management of HIV because it contributes to:</p>
<ul>
<li>Reducing risk and frequency of other infections</li>
<li>Delaying progression from HIV infection to AIDS</li>
<li>A healthy appearance and weight</li>
</ul>
<p>28</p>
<p>Gaining strength, maintaining and building muscle, and having energy to remain active
Reducing side effects of ART.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-2-2-nutritional-assessment-counselling-and-support-nacs">3.2.2: Nutritional assessment, counselling and support (NACS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-2-2-nutritional-assessment-counselling-and-support-nacs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Anthropometric: Mid upper arm circumference (MUAC), BMI- Provide interpretation and required actions for anthropometric results for children and adults.</p>
<p>Biochemical investigations for baseline and follow-up investigations e.g viral load, CD4 count, pregnancy, urinalysis etc.</p>
<p>Clinical physical examination for initial evaluation</p>
<p>Dietary (24 hour recall for food type/frequency and household food security)</p>
<p>Environmental and psychosocial</p>
<p>Functional (ability to care for self, bedridden, etc.)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-2-3-counselling-and-education">3.2.3: Counselling and education<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-2-3-counselling-and-education" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Benefits of maintaining good nutritional status for a person living with HIV</p>
<p>Mother infant and young child nutrition (MIYCN)</p>
<p>Reassuring the client that it is possible to attain/maintain good nutritional status, look well and live a healthy life</p>
<p>Identifying locally available foods they can access given their own context, food safety and food preparation</p>
<p>Helping the client to plan meals and snacks with a variety of foods in order to meet their energy and nutrient needs and treatment plans</p>
<p>Identifying any constraints the client may face and find ways to minimize them</p>
<p>Helping the client to understand the potential side effects and food interactions of the medicines they are taking, and help the client identify ways to manage these side effects</p>
<p>Exploring with the client the cause(s) of poor appetite and appropriate responses (type of food, disease, pain, depression, anxiety, or side effects of medications)</p>
<p>29</p>
<p>Counselling on high levels of sanitation and food hygiene</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-2-4-nutritional-support">3.2.4: Nutritional support<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-2-4-nutritional-support" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Therapeutic and supplementary foods to treat clinical malnutrition (food by prescription, therapeutic feeds, fortified blended four)</p>
<p>Complementary foods for children aged 6 - 23 months to prevent malnutrition</p>
<p>Micronutrient supplements to prevent vitamin and mineral deficiencies</p>
<p>Point-of-use water purification to prevent water-borne disease</p>
<p>Food security and linkage to community, such as household food support, home-based care, agricultural extension services, and economic strengthening.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-2-5-food-security-components-of-hiv-aids">3.2.5: Food security components of HIV&amp;AIDS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-2-5-food-security-components-of-hiv-aids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Food security can be attained through linkage to community, such as household food support, home-based care, agricultural extension services, and economic strengthening.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-2-6-relationship-between-hiv-and-nutrition">3.2.6: Relationship between HIV and nutrition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-2-6-relationship-between-hiv-and-nutrition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>An HIV-infected person is more at risk for malnutrition for the following reasons:</p>
<ol>
<li>Reduced food intake. Adults with HIV/AIDS suffer from appetite loss (anorexia) and have difficulty eating.</li>
<li>Poor absorption. HIV/AIDS affects how the body uses the foods that are consumed, resulting in poor absorption of nutrients (protein, carbohydrates, fats, vitamins, minerals and water). Poor absorption of nutrients accompanies diarrhea, which is common with HIV infection.</li>
<li>Changes in metabolism. With poor nutrient absorption, individuals may not be able digest foods efficiently and therefore the body may not be able to use the nutrients properly, particularly fats, carbohydrates and proteins.</li>
<li>Chronic infections and illnesses. Fevers and infections that accompany an HIV infection lead to greater nutrient requirements and poor use of the nutrients by the body.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-2-7-illnesses-associated-with-nutritional-impacts">3.2.7: Illnesses Associated with Nutritional Impacts<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-2-7-illnesses-associated-with-nutritional-impacts" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>30</p>
<p>Anorexia
Diarrhea
Fever
Nausea/frequent vomiting
Thrush
Anaemia</p>
<p>Signs of Malnutrition
Swollen body and feet
Pale skin, eyes, hair
Lack of blood
Underweight
Thinness
Muscle wasting</p>
<p>3.2.8: Infant and young child feeding in HIV/AIDS</p>
<p>Adequate nutrition is especially important for young children, to ensure they grow properly and have sufficient nutrients to boost their immune systems and fight infection. A malnourished child is more susceptible to various infections, leading to inadequate physical growth, reduced cognitive development and a higher risk of mortality.</p>
<p>Because HIV-infected children are at higher risk of malnutrition and growth failure, the following problems should receive special medical attention:</p>
<ol>
<li>Inadequate food intake resulting from poor appetite, eating very little or high degree of selectivity around food choices.</li>
<li>Stomach pain.</li>
<li>Feeding difficulties: poor sucking, swallowing or breathing reflex.</li>
</ol>
<p>3.2.8.1: Advantages of breast milk/breast feeding</p>
<ol>
<li>It is safe, clean, hygienic, cheap and available to infants at correct temperature.</li>
<li>It fully meats the nutritional requirements of the infants in the first few months of life.</li>
</ol>
<p>31</p>
<ol start="3">
<li>It contains the microbial factors such as macrophages, lymphocytes, secretory, IgA, antistreptococcal which provide protection not only against diarrheal diseases and enterocolitis but also against respiratory tract infections in the first months.</li>
<li>It is easily digested and utilized by both the normal and pre term babies.</li>
<li>It promotes bonding between the mother and the baby.</li>
<li>Sucking is good for the baby- it helps in development of the jaw and teeth.</li>
<li>It protects the babies from the tendency to obesity</li>
<li>It prevents malnutrition and reduces infant mortality.</li>
<li>It provides several bio-chemical advantages such as prevention of neonatal hypocalcaemia and hypo-magnesaemia.</li>
<li>It helps parents to space their children by prolonging the period of infertility.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-3-psychological-counseling-and-testing">3.3: Psychological counseling and testing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-3-psychological-counseling-and-testing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>People living with HIV are susceptible to psychological disturbances due to HIV itself and perceptions regarding HIV in their environment.</p>
<p>Some of the most common psychological disturbances include depression and suicide, anxiety, internalized stigma, post-traumatic stress disorder, cognitive difficulties such as dementia, and perceived lack of social support. Any of these can significantly interfere with a patient’s sense of well-being and their adherence; however depression and alcohol/ drug addiction are the most significant.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="depression">Depression<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#depression" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>People living with HIV (PLHIV) are 3-6 times more likely to suffer from depression than the general population, with significant disability and poorer treatment outcomes if it is not identified and managed. Depression can be a significant contributing factor to poor adherence and HIV treatment failure.</p>
<p>All PLHIV should receive basic screening for depression before initiating ART and thereafter annually using the following two questions:</p>
<blockquote>
<p>During the past two weeks, have you often been bothered by feeling down, depressed or hopeless?</p>
</blockquote>
<p>During the past two weeks, have you often been bothered by little pleasure in doing things?</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="supportive-counselling-for-depression">Supportive Counselling for Depression<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#supportive-counselling-for-depression" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Patients with mild depression should receive support counselling, which includes;</p>
<ul>
<li>Depression is common and can happen to anyone</li>
<li>Depressed people often have exaggerated negative opinions about themselves, their life and their future</li>
<li>Effective treatment is possible</li>
<li>Self-management includes;</li>
<li>Continue ART as prescribed</li>
<li>Continuing activities that they used to find interesting/pleasurable</li>
<li>Maintaining a regular sleep cycle</li>
<li>Keep physically active. Participate in community/social events</li>
<li>Return if any thoughts of self-harm</li>
<li>Address psychosocial stressors</li>
<li>Explore potential stressors in the patient’s life</li>
<li>Assist in problem-solving to reduce stressors</li>
<li>Assess for gender based violence</li>
</ul>
<p>Referral to social networks e.g support groups</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-3-1-role-of-cha-in-management-of-stigma">3.3.1: Role of CHA in management of stigma<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-3-1-role-of-cha-in-management-of-stigma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Begin with yourself. Examine your own attitudes, assumptions, and beliefs about TB/HIV/AIDS and people living with TB, HIV/AIDS.</p>
<ul>
<li>Reach out to your family and community. Examine the role that you can play to promote dialogue, understanding, and support for people living with TB, HIV, and AIDS in your workplace, family, and community.</li>
<li>Learn and grow. Stigma and discrimination are rooted in ignorance and fear. You can avoid this by following up-to-date information pertaining to TB, HIV/AIDS.</li>
</ul>
<p>33</p>
<ul>
<li>Express your knowledge. Share your knowledge on TB/HIV/AIDS, especially about how TB/HIV is and is not transmitted. Find creative ways and real-life stories to share information with your colleagues, TB patients, family members, and community.</li>
<li>Effect change. As an individual or group, advocate to end TB/HIV/AIDS-related stigma and discrimination in your workplace, family, and the community at large, and promote improved care and support for people living with TB/HIV/AIDS.</li>
</ul>
<p>Think positively. Speak out and mobilize others to speak out against TB/HIV/AIDS-related stigma and discrimination. Use language that acknowledges and accepts people living with TB/HIV/AIDS as part of your family, workplace, and community. Listen to and honour the courageous voices and experiences of people living with TB, HIV, and AIDS.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-4-reporting-adverse-drug-reactions-adrs">3.4: Reporting adverse drug reactions (ADRs)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-4-reporting-adverse-drug-reactions-adrs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Once patients have been on ART for several months, ADRs are unlikely. ADRs can have a significant impact on patient adherence and must be identified early and managed aggressively. All ADRs should be reported to the Pharmacy and Poisons Board using existing pharmacovigilance tools. The most common significant ADRs associated with ARVs that may require a drug substitution.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-5-defaulter-tracing">3.5: Defaulter tracing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-5-defaulter-tracing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-5-1-definition">3.5.1: Definition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-5-1-definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Identifying, Tracing and Supporting Patients who Default from Care.</p>
<p>Every service delivery point that is providing ARVs for patients (whether ART, PEP, or PrEP) must have a functional system for identifying patients who miss appointments and for taking action within 24 hours of a missed appointment.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="3-5-2-steps-in-identifying-tracing-and-supporting-defaulters">3.5.2: Steps in identifying, tracing and supporting defaulters<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-5-2-steps-in-identifying-tracing-and-supporting-defaulters" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>i. After visit, enter date of next appointment for each patient in the appointment diary.
ii. All patients who had appointment for the day but did not attend should be recorded
iii. Patients/caregivers should be called within 72 hours of missed appointment</p>
<p>34</p>
<p>If no response, treatment buddy should be called</p>
<p>iv. Update patient follow up register with phone call responses
v. Can't be reached on phone or unable to return to clinic within 7 days (prioritize home visits)</p>
<p>Patient dead or declines further contact- prioritize home visit</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-6-networking-for-access-to-care">3.6: Networking for access to care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-6-networking-for-access-to-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-6-1-concepts-in-networking">3.6.1: Concepts in networking<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-6-1-concepts-in-networking" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>HIV counselling and testing is just the first step in the continuum of HIV care; a positive HIV diagnosis without linkage to HIV prevention, care and treatment confers limited benefit. Ensuring that people are linked to and enrolled in HIV clinical care is necessary to realize the full health and prevention benefits of ART. Unfortunately, substantial losses occur at every step of the HIV care continuum. These losses can be particularly great among people from key populations.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="reasons-for-losses-include">Reasons for losses include;<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reasons-for-losses-include" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Psychological and social barriers. A number of psychological and social barriers hinder linkage to care for people newly diagnosed with HIV. The perceived stigma associated with attending an HIV clinic continues to be a barrier to early care enrolment. Lack of family support and fear of disclosure also hinder access</p>
<p>Economic constraints. Migration in search of employment opportunities and an inability to miss work to attend clinical appointments, may also inhibit enrolment in HIV clinical care.</p>
<p>Health system factors affecting linkage to care include reliance on passive referral as the only linkage strategy, inadequate staffing, long wait times, poor service offered in HIV clinics, and poor attitudes of health-care staff.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-6-2-approaches-to-improve-linkage-to-care-and-treatment">3.6.2: Approaches to Improve Linkage to Care and Treatment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-6-2-approaches-to-improve-linkage-to-care-and-treatment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>36</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="strategy-and-action">Strategy and Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#strategy-and-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Information- Quality post-test counselling should include information about the nature and availability of additional HIV-related services, describe next steps in care and treatment including entire treatment plan and follow-up visits and schedule. The benefits of immediate assessment and early initiation of ART should be emphasized. Involve the patient in the decision making process regarding care and treatment (especially where and when to start ART)</p>
<p>Disclosure- Disclosure to a trusted ‘significant other’ promotes linkage and adherence to treatment. Encourage and help the patient to discuss HIV status with a trusted friend or close relative. Encourage adolescents to identify and invite a supportive adult or friend to support them</p>
<p>Barriers to Linkage- During post-test counselling, identify and address any barriers to linkage</p>
<p>System to Facilitate Linkage to treatment services through patient escorts. Where this is not possible (due to patient preference or the services are not available), the testing facility should book the appointment with the receiving facility and follow-up to ensure the patient registers at the receiving facility.</p>
<p>Provide the patient with referral information, referral form and contact details of the facility to ensure linkage is successful. These include enlisting the help of peer or buddy systems, SMS reminders, phone calls and community outreach workers to escort HIV positive clients to enrolment strengthens engagement in care</p>
<p>Care Coordination and Integration - Coordinate and treat mother-baby pairs, partners and families together. Integrate common services offered to PLHIV (TB diagnosis and treatment, SRH/FP, cervical screening, nutrition etc.). Where referrals are necessary, such referrals should be coordinated (communication and documentation between referring and receiving service delivery points).</p>
<p>Linkage Register - Maintain a linkage register at all testing points in the facility and community. Track and report on progress with linkage on a monthly basis. Discuss linkage</p>
<p>3.7: Criteria for referral and referral procedures</p>
<p>3.7.1: Definition</p>
<p>Referral is defined as the process through which a client is moved or moves through the continuum of treatment, care and support. The concept of referral is similar to that of linkage to care, and the terms are sometimes used interchangeably a hand-off of a patient or client to another service.</p>
<p>A referral system is dynamic and links an individual seeking care and support to a variety of services.</p>
<p>If the HIV testing facility does not provide comprehensive HIV care and treatment services, or if testing was conducted in an outreach setting, a referral is made to an appropriate facility.</p>
<p>The referral process should include helping patients connect to services. This includes setting up of appointments, giving directions to the facility, sending contact details of the patient to the referral facility and following-up to ensure contact between the patient and the service providers in the referral facility. The tester should also make contact with the point person at the referral facility.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-7-2-types-of-referrals">3.7.2: Types of referrals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-7-2-types-of-referrals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Passive referral: A referral form containing details of the patient is generated and given to the patient from the referring facility to submit to the referral facility by the patient.</p>
<p>Active referrals is done though patient escorts to the referred health facility</p>
<p>Referral services include: Prevention, advocacy, spiritual support, Psychosocial support, Nutrition support, social and legal support services, peer support, community based services, HIV clinics, specialized care facilities and hospitals for treatment of other conditions.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-7-3-elements-of-referral-network">3.7.3: Elements of referral network<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-7-3-elements-of-referral-network" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>A group of organizations that, in the aggregate, provide comprehensive services to meet the needs of PLHIV, their caregivers and their families within a defined geographic area</li>
<li>A unit or organization that coordinates and oversees the whole referral network</li>
<li>Periodic meetings of network providers</li>
<li>Designated referral person(s) at each organization</li>
<li>A directory of services and organizations within a defined catchment area</li>
<li>A standardized referral form</li>
</ol>
<p>37</p>
<ol start="7">
<li>A feedback loop to track referrals</li>
<li>Documentation of referral</li>
</ol>
<p>3.8: Standard Package of Care for PLHIV Consists of 8 components</p>
<p>a. Antiretroviral Therapy</p>
<ul>
<li>All PLHIV qualify for ART irrespective of CD4 cell count or percentage, WHO clinical stage, age, pregnancy status, or comorbidities</li>
<li>ART should be initiated as soon as the patient is ready to start, preferably within two weeks from time of HIV diagnosis.</li>
</ul>
<p>&lt;2wks- AZT,3TC,NVP.
2-4WKS AZT,3TC,LPV/r.
4WKS-3YRS; ABC,3TC,LPV/r.
3-15YRS; (&lt;35kg) ABC,3TC,EFV while those weighing &gt;35kg
useTDF,3TC,EFV.
&gt;15 YRS TDF,3TC,EFV which is also the first line ARVs for Adult PLHIV.</p>
<p>b. Positive Health, Dignity, and Prevention, GBV &amp; Health Education and Counselling</p>
<p>All patients should be counselled and supported for disclosure of HIV status; partner/family testing and engagement; condom use; family planning; sexually transmitted infections screening; and treatment adherence services
All females aged 15-49 years and emancipated minors accessing HIV care services should be screened for Gender Based Violence (GBV) as part of the standard package of care
All PLHIV should be provided with health education and counselling</p>
<p>c. Screening for and Prevention of Specific Opportunistic Infections</p>
<p>38</p>
<ul>
<li>
<p>All PLHIV should receive lifelong cotrimoxazole prophylactic therapy (CPT) unless they have allergy to sulfa drugs or develop toxicity from CPT</p>
</li>
<li>
<p>During pregnancy, CPT should be initiated irrespective of the gestational age and should continue throughout pregnancy, breastfeeding, and thereafter for life</p>
</li>
<li>
<p>When dapsone (as a substitute for CPT) is being used as PCP prophylaxis, it is only recommended for patients in WHO Stage 4 and/or absolute CD4 count &lt; 200 cells/mm3 (or CD4% &lt; 25% for children ≤ 5 years old), and should be discontinued once a patient achieves a sustained CD4 count of &gt; 200 cell/mm3 (or &gt; 25% for children ≤ 5 years old) for at least 6 months.</p>
</li>
<li>
<p>All PLHIV should be screened for TB at every visit using the Intensified Case Finding (I CF) tool and assessed for Isoniazid Preventive Therapy (IPT) if screened negative for TB</p>
</li>
<li>
<p>All adult PLHIV with a baseline CD4 count of ≤ 100 cells/mm3 should be screened for cryptococcal meningitis (CM) using the serum CrAg test.</p>
</li>
</ul>
<p>d. Reproductive Health Services</p>
<ul>
<li>
<p>All PLHIV should be screened for STI at every clinic visit</p>
</li>
<li>
<p>Pregnancy status should be determined for all women of reproductive age at every visit and their contraception need determined and met</p>
</li>
<li>
<p>All HIV positive women between the ages of 18 - 65 years should be screened for cervical cancer</p>
</li>
</ul>
<p>e. Screening for and Management of Non-Communicable Diseases</p>
<p>Lifestyle modifications are always the first line of prevention and management for hypertension, diabetes mellitus, and dyslipidaemia</p>
<p>f. Mental Health Screening and Management</p>
<p>All PLHIV should receive basic screening for depression before initiating ART, as indicated and annually thereafter if not indicated</p>
<p>39</p>
<p>All adults and adolescents should be screened for alcohol and drug use before initiating ART and regularly during follow-up</p>
<p>g. Nutrition Services</p>
<p>All PLHIV should receive nutritional assessment, counselling, and support tailored to the individual needs of the patients</p>
<p>h. Prevention of Other Infections</p>
<p>PLHIV (including children) should receive vaccinations as recommended by the National Vaccines and Immunization Programme</p>
<p>3.9: Role of community health assistant in management of HIV</p>
<ul>
<li>Refer people living with HIV for care and treatment- ensure access to health workers providing quality care; and drive investment and accountability through political leadership</li>
<li>Tracing of TB and ART defaulters- Follow doctor's orders about your prescriptions.</li>
<li>Sensitizing the community on HIV</li>
<li>Counseling- Manage physical and emotional health problems</li>
<li>Practice safe sex. This is paramount on the list.</li>
<li>Enable individuals and communities affected by HIV to take charge of their own health and that of their loved ones;</li>
<li>Get tested for other STDs.</li>
<li>Prevent infections and illnesses.</li>
<li>Don't abuse drugs or alcohol and quit smoking.</li>
<li>Exercise mind and body.</li>
</ul>
<p>40</p>
<p>UNIT 4: SOCIAL BEHAVIOR CHANGE COMMUNICATION (SBCC) (10 Hours)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-1-concepts-of-sbcc">4.1: Concepts of SBCC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-1-concepts-of-sbcc" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>SBCC is the strategic use of communication to promote positive health outcomes, based on proven theories and models of behaviour change.</p>
<p>SBCC consists of effective communication which is central to the success of interventions to reduce the risk of HIV infection. Enhanced knowledge about the behavior change process has facilitated the design of communications programs to reduce the risk of HIV transmission and AIDS.</p>
<p>The process of behavior change:</p>
<p>Behavior change theories and models</p>
<p>These include;</p>
<ol>
<li>The Diffusion of Innovations model (Everett Rogers)</li>
<li>The Stages of Change model (Prochaska, DiClemente and Norcross)</li>
<li>The Self-Efficacy model (Bandura)</li>
<li>The Behavior Change Continuum (World Bank).</li>
</ol>
<p>Stages of behavior change continuum</p>
<p>Unaware</p>
<p>Aware</p>
<p>41</p>
<p>Concerned</p>
<p>Knowledgeable</p>
<p>Motivated to change</p>
<p>Practicing trial behavior change</p>
<p>Practicing sustained behavior change</p>
<p>Enabling factors</p>
<p>Providing effective communication</p>
<p>Creating an enabling environment; policies, community values, human rights</p>
<p>Providing user friendly, accessible services and commodities.</p>
<p>Channels of communication in SBCC</p>
<p>i. Inter Personal Communication (IPC)
ii. Counseling
iii. Group discussions/communication
iv. Edutainment e.g. songs, folk dances, street shows, dramas, Community networks and traditional media
v. Mass media: print media e.g. newspapers, posters, flyers, leaflets, booklets etc., or electronic media including radio, television and online/digital platforms and the Internet.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-2-goals">4.2: Goals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-2-goals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Social behavior change communication goals need to be developed in the context of overall program goals and specific behavior change goals e.g reduce the risk of HIV infections.. The following highlights the place of BCC goals within an overall program. SBCC goals are related to specific issues identified when assessing the situation, knowledge, attitudes and skills that may need to be changed to work toward behavior change and program goals.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-3-guiding-principles">4.3: Guiding principles<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-3-guiding-principles" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>SBCC is different from the ordinary instructional method of communication and is target specific. The strategy for SBCC will vary from group to group.</p>
<ol>
<li>SBCC should be integrated with program goals from the start- SBCC is an essential element of HIV prevention, care and support programs, providing critical linkages to other program components, including policy initiatives.</li>
<li>Formative SBCC assessments must be conducted to improve understanding of the needs of target populations, as well as of the barriers to and supports for behavior change that their members face (along with other populations, such as stakeholders, service providers and community).</li>
<li>The target population should participate in all phases of SBCC development and in much of implementation.</li>
<li>Stakeholders need to be involved from the design stage.</li>
<li>Having a variety of linked communication channels is more effective than relying on one specific one.</li>
<li>Pre-testing is essential for developing effective SBCC materials.</li>
<li>Planning for monitoring and evaluation should be part of the design of any SBCC program.</li>
<li>SBCC strategies should be positive and action-oriented.</li>
<li>PLWHA should be involved in SBCC planning and implementation.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-4-role-of-sbcc">4.4: Role of SBCC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-4-role-of-sbcc" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Increase knowledge- SBCC can ensure that people are given the basic facts about HIV and AIDS in a language or visual medium</p>
<p>Stimulate community dialogue- SBCC can encourage community and national discussions on the basic facts of HIV/AIDS and the underlying factors that contribute to the epidemic, such as risk behaviors and risk settings, environments and cultural practices related to sex and sexuality, and marginalized practices (such as drug use) that create these conditions</p>
<p>Promote essential attitude change- SBCC can lead to appropriate attitudinal changes for example, perceived personal risk of HIV infection, belief in the right to and responsibility</p>
<p>43</p>
<p>for safe practices and health supporting services, compassionate and non-judgmental provision of services, greater open-mindedness concerning gender roles and increasing the basic rights of those vulnerable to and affected by HIV and AIDS.</p>
<p>Advocate for policy changes- SBCC can lead policymakers and opinion leaders toward effective approaches to the epidemic.</p>
<p>Create a demand for information and services- SBCC can spur individuals and communities to demand information on HIV/AIDS and appropriate services.</p>
<p>Reduce stigma and discrimination- Stigma is a mark of shame or discredit on a person or group. Stigma can manifest itself in a variety of ways, from ignoring the needs of a person or group to psychologically or physically harming those who are stigmatized</p>
<p>Promote services for prevention and care- SBCC can promote services for STIs, intravenous drug users (IDUs), orphans and vulnerable children (OVCs); voluntary counseling and testing (VCT) for mother-to-child transmission (MTCT); support groups for PLHA; clinical care for opportunistic infections; and social and economic support. SBCC is also an integral component of these services.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-4-framework-for-sbcc-design">4.4: Framework for SBCC design<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-4-framework-for-sbcc-design" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Steps in developing SBCC</p>
<p>i. State program goals
ii. Involve stakeholders
iii. Identify target populations
iv. Conduct formative SBCC assessments
v. Segment target populations
vi. Define behavior change objectives
vii. Design SBCC strategy and Monitoring and Evaluation (M&amp;E) Plan
viii. Develop communication products
ix. Choose partners
x. Conduct pre-testing
xi. Implement</p>
<p>xii. Monitoring and evaluation</p>
<p>4.5: Community prevention with positive key messages</p>
<ol>
<li>
<p>Get tested for HIV. Talk to your partner about HIV testing and get tested before you have sex. Use this testing locator from the Centers for Disease Control and Prevention (CDC) to find an HIV testing location near you.</p>
</li>
<li>
<p>Choose less risky sexual behaviors. HIV is mainly spread by having anal or vaginal sex without a condom or without taking medicines to prevent or treat HIV.</p>
</li>
<li>
<p>Use condoms every time you have sex. Read this fact sheet from CDC on how to use condoms correctly.</p>
</li>
<li>
<p>Limit your number of sexual partners. The more partners you have, the more likely you are to have a partner with poorly controlled HIV or to have a partner with a sexually transmitted disease (STD). Both of these factors can increase the risk of HIV transmission.</p>
</li>
<li>
<p>Get tested and treated for STDs. Insist that your partners get tested and treated, too. Having an STD can increase your risk of getting HIV or spreading it to others.</p>
</li>
<li>
<p>Talk to your health care provider about pre-exposure prophylaxis (PrEP). PrEP is an HIV prevention option for people who don't have HIV but who are at risk of getting HIV. PrEP involves taking a specific HIV medicine every day to reduce the risk of getting HIV through sex or injection drug use. For more information, read the ClinicalInfo fact sheet on Pre-Exposure Prophylaxis (PrEP).</p>
</li>
<li>
<p>Don't inject drugs. But if you do, use only sterile drug injection equipment and water and never share your equipment with others.</p>
</li>
</ol>
<p>4.6: Living with HIV and AIDS</p>
<ol>
<li>
<p>Starting antiretroviral treatment as soon as possible, and sustaining it as part of your everyday routine, is the best way of ensuring that your immune system stays strong.</p>
</li>
<li>
<p>Immediate attention for illnesses- Illnesses and infections are signs that the body is weak. If left untreated, they can lead to further deterioration. Quick attention to early signs of illness can prevent further damage to the body.</p>
</li>
<li>
<p>Exercising regularly- Being active is a part of maintaining your health for everyone – it builds muscle, keeps your bones strong, your heart healthy and burns fat.</p>
</li>
<li>
<p>Eating well- Eat a balanced diet, without too much processed fat, sugar or salt. Provides the energy and nutrients your body needs to fight HIV and other infections, maintains a healthy weight, manages HIV symptoms and complications and improves absorption of medicines and helps manage potential side effects.</p>
</li>
<li>
<p>Safer sexual and reproductive health practices. Programs could promote the use of condoms and avoidance of unprotected sex, especially among persons whose HIV status is not known. Having protected sex will lead to healthier and more productive lives by:</p>
</li>
</ol>
<ul>
<li>Reducing further spread of the virus</li>
<li>Reducing the risk of repeated exposure to HIV infection, (repeated exposure can speed up the disease process in the body of an HIV-infected person);</li>
<li>Avoiding pregnancy, (pregnancy puts greater strain on a woman's health and risks possible infection of the baby).</li>
<li>Preventing exposure to other sexually transmitted diseases, (exposure to sexually transmitted diseases can lead to severe morbidity or premature mortality)</li>
<li>Avoiding infection in women and therefore the possibility of transferring it to their infants.</li>
</ul>
<ol start="6">
<li>
<p>Avoid excessive alcohol and drug use- Alcohol can damage the liver which the body uses to process anti-HIV drugs, so it is good to keep your alcohol consumption within the recommended limits. Heavy drinking and taking recreational drugs can also weaken your immune system, making it harder for your body to recover from infections.</p>
</li>
<li>
<p>Getting enough rest</p>
</li>
<li>
<p>Quality sleep are all vital to maintaining your health.</p>
</li>
<li>
<p>Psychosocial support- Your mental wellbeing is just as important as your physical health. Manage stress and get support. Talking about your concerns with family, friends or a support group can really help.</p>
</li>
</ol>
<p>4.7: Challenges of communication</p>
<ol>
<li>Integrating SBCC into all programs. SBCC is a component of all successful interventions and must be included in their original design. However, in reality this</li>
</ol>
<p>46</p>
<p>doesn't always happen. It is essential to identify opportunities for improving the quality of communication components.</p>
<ol start="2">
<li>
<p>Limited training resources. Limited capacity and availability of trained, in-country resource people, including advertising agencies and media outlets, can hamper the effective implementation of SBCC programs.</p>
</li>
<li>
<p>Political and physical environments. In some countries, geography and populational diversity can complicate the development of SBCC programs. This is especially the case where vast distances must be covered, or multiple languages and cultural traditions included, in a single country program.</p>
</li>
<li>
<p>Sustainability. To be effective, SBCC strategies and components must evolve constantly to meet the changing needs of target populations. This requires the continuous input of human and financial resources.</p>
</li>
<li>
<p>Expanding the response. To have a real impact on the epidemic, responses must be expanded in quality, scope of activities and geographic coverage. Expanding comprehensive SBCC strategies is a continuing challenge.</p>
</li>
<li>
<p>Budgets. The steps necessary to develop a comprehensive SBCC strategy are often not adequately budgeted. For example, a budget will be prepared for the production of materials but not for the process necessary to develop the appropriate content. Capacity-building needs are ongoing and resource-intensive and this must be taken into consideration. Donors and managers need to understand the costs and benefits associated with SBCC activities.</p>
</li>
<li>
<p>Linkages and coordination. For SBCC to be effective, their messages and information should be coordinated. Building and maintaining linkages and coordination is an ongoing challenge.</p>
</li>
</ol>
<p>47</p>
<p>UNIT 5: HOME AND COMMUNITY BASED CARE (HCBC) (10 Hours)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-1-concepts-of-hcbc">5.1: Concepts of HCBC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-1-concepts-of-hcbc" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="5-1-1-definition">5.1.1: Definition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-1-1-definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Home based care is the care an HIV/AIDS person receives that is extended from the hospital or health care facility to the patient's home through family participation and community involvement within available resources and in collaboration with health care worker.</p>
<p>This is a collaborative effort between hospital, family and community. It includes components such as physical, psychological and spiritual support.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="5-1-2-objectives">5.1.2: Objectives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-1-2-objectives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>i. To facilitate the continuity of care of the PLWHA from the health facility to the home and community.</p>
<p>ii. To promote family and community awareness of HIV/AIDS prevention and care.</p>
<p>iii. To empower the PLWHA, the family, and the community with the knowledge needed to ensure long-term care and support.</p>
<p>iv. To empower the PLWHA in self-care and positive living.</p>
<p>v. To facilitate quality community care for the infected and affected.</p>
<p>vi. To raise the acceptability levels of PLWHAs by the family/community in order to reduce the stigma associated with AIDS.</p>
<p>48</p>
<p>vii. To streamline the patient/client referral from the institutions into the community and from the community to appropriate health and social facilities.</p>
<p>viii. To mobilize the resources necessary for sustainability of the service.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-1-3-rationale">5.1.3: Rationale<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-1-3-rationale" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The rationale for emphasizing home-based care rests in its benefits to PLWHAs, the families of PLWHAs, the community, and the healthcare system:</p>
<ol>
<li>Home-based care allows persons living with HIV/AIDS to take responsibility for their own welfare and well-being; receive care in a familiar environment; continue participating in family affairs; retain a sense of belonging to social groups; and accept their condition more easily.</li>
<li>Home-based care contributes to family solidarity; helps the family accept the infected person's condition; makes it easier to provide care/support; can reduce health care costs; and makes it easier for family members who provide care to attend to other responsibilities.</li>
<li>At the community level, home-based care helps reduce health care costs; affords opportunities for community members to confront stigma and provide support to persons living with HIV/AIDS; contributes to community cohesiveness; and raises awareness about the causes and impact of HIV/AIDS.</li>
<li>The health care system benefits because home-based care helps ease the demand on health care facilities; does not require the creation of extra services where none exist; and extends responsibility to individuals, families, and communities</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-1-4-role-of-various-stakeholders">5.1.4: Role of various stakeholders<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-1-4-role-of-various-stakeholders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="providers-of-home-based-care">Providers of Home Based Care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#providers-of-home-based-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>The patient: provides own care if not very sick</li>
<li>The family members: relative friends and community members, to enable families take care of the infected person at home, there is need for health care worker to guide, advice (education) and counseled on home based care, nursing skills, psychological and material support. Families often face difficulties of certain death, and different types of illness --- increased care.</li>
<li>Health care workers: CBHW, CBO, traditional healers, and faith based organization.</li>
</ol>
<p>49</p>
<p>50</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="key-players-of-home-based-care">Key players of home based care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-players-of-home-based-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>The health facility: Making the initial diagnosis and delivering clinical care, recruiting the PLWHA into the programme, identifying needs at various levels, preparing the PLWHA for discharge home, preparing the family caregiver for the caring responsibility at home, supplying simple drugs and basic home nursing supplies, facilitating training and supervision of community health workers in home care and the use of simple drugs and supplies, caring for terminally ill PLWHAs depending on their wish. Some non-clinical aspects of these functions may be filled by non-government/community-based organizations or other responsible entity.</p>
</li>
<li>
<p>The family and other caregivers: Caring for the PLWHA at home, collaborating with other care providers, e.g., religious institutions, support groups, and health and social institutions, consulting and involving the PLWHA on matters concerning them, accepting the reality of the situation, and helping the PLWHA to prepare for death.</p>
</li>
<li>
<p>The community: Accepting the situation of the PLWHA, collaborating with existing agencies to meet the needs of those infected, forming support groups, advocating for the rights of PLWHAs.</p>
</li>
<li>
<p>The PLWHA/patient: Identifying the primary or alternative caregiver, participating in the care process, writing a will, identifying own spiritual/pastoral needs, resolving to take personal responsibility to stop the further transmission of HIV, advocating for behaviour change.</p>
</li>
<li>
<p>The government: Creating a supportive policy environment, developing policies and guidelines, developing and maintaining standards, providing/coordinating training, providing drugs and commodities.</p>
</li>
<li>
<p>Health worker</p>
</li>
<li>
<p>Spiritual leader</p>
</li>
<li>
<p>CHVs</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="responsibilities-of-the-family-to-the-infected-person-in-home-based-care">Responsibilities of the family to the infected person in Home Based Care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#responsibilities-of-the-family-to-the-infected-person-in-home-based-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Maintain physical strength and fitness e.g. nutrition, rest, exercises.</p>
<p>Treating symptoms by correctly administering prescribed medication, and appropriately referring to the health care facility.</p>
<p>Meeting the person social and emotional needs
Prevention of transmission of infection to patient and others
Securing the needed assistance
Follow up</p>
<p>Responsibilities of the health care workers in Home Based Care
Educating and guiding family on Home Based Care
Prevention of infection
Follow up at home
Prescribing medication
Respond to referrals
Hospitalize
Link patient and family with resource in the community.</p>
<p>5.2: Components</p>
<ol>
<li>Clinical care: this includes early diagnosis, rational treatment and planning for follow up care for HIV/AIDS related illness.</li>
<li>Nursing care: is aimed at promoting and maintaining good health for the infected person e.g. hygiene, nutrition.</li>
<li>Counseling and psychological care to include:
Reducing stress and anxiety
Promoting positive living
Helping the individual make informed decisions/ choices on HIV testing, plans for the future, behavior change and involve sexual partner(s) in such decisions</li>
<li>Social support: the person is given information about social support groups, welfare services and legal advice for the individual and family. Surviving family members are involved and where possible provision of material assistance.</li>
<li>Palliative care: care for patients with terminal diseases e.g. cancer</li>
<li>Community mobilization
In community mobilization, both the national and even global communities have emerged with shared concerns to prevent the spread of the virus, to care for those affected by HIV and AIDS, and to advocate for health and human rights.</li>
</ol>
<p>51</p>
<p>A ``mobilized community'' has the following characteristics:</p>
<ul>
<li>Members are aware - In a detailed and realistic way — of their individual and collective vulnerability to HIV/AIDS.</li>
<li>Members are motivated to do something about this vulnerability.</li>
<li>Members have practical knowledge of the different options they can take to reduce their vulnerability.</li>
<li>Members take action within their capability, applying their own strengths and investing their own resources — including money, labour, materials or whatever else they have to contribute.</li>
<li>Members participate in decision-making on what actions to take, evaluate the results, and take responsibility for both success and failure.</li>
<li>The community seeks outside assistance and cooperation when needed.</li>
</ul>
<p>Challenges of community mobilization</p>
<ul>
<li>Time and energy expected from community members-activities depend on CHVs</li>
<li>Rigid pre-set expectations</li>
<li>Pre-determined lifespans of initiatives-</li>
<li>Incomplete participation or representation</li>
<li>Coping with success: from mobilization to management</li>
</ul>
<p>52</p>
<p>UNIT 6: SEXUALLY TRANSMITTED INFECTIONS (STI) (6 Hours)</p>
<p>6.1: Definition
Sexually transmitted diseases are a group of communicable diseases that are transmitted predominantly by sexual contact.</p>
<p>6.2: Classification</p>
<ol>
<li>Bacteria</li>
<li>Fungal</li>
<li>Parasite</li>
<li>Viral</li>
<li></li>
</ol>
<p>6.4: Risk factors
Biological risk factors</p>
<ul>
<li>Age,</li>
<li>Sex,</li>
<li>Immune status of the host</li>
<li>Virulence of the organism
Behavioral risk factors</li>
<li>Multiple sexual partners</li>
<li>Sex with commercial sex workers - prostitution</li>
<li>Unprotected sexual intercourse</li>
</ul>
<p>53</p>
<p>Homosexuals- Men who have sex with other men</p>
<p>Drug and substance abuse- leads to high risky behaviors</p>
<p>Social-cultural risk factors</p>
<ul>
<li>Polygamy- marry more than one wives</li>
<li>Some societies, men’s risky behavior of multiple sexual partners is tolerated</li>
<li>Early girl- child marriages to adults exposes the girl to infection</li>
<li>High numbers of single poorly paid and unemployed young people</li>
<li>Rural Urban migration</li>
<li>Sexual intercourse for pleasure and gain</li>
<li>Occupations involving a lot of travelling: Long distance drivers, soldiers, and sailors</li>
<li>Broken homes- divorce, separation, death of one partner, sexual disharmony</li>
</ul>
<p>6.5: Types of STIs</p>
<p>Syphilis</p>
<p>It is contagious sexually transmitted disease caused by the bacteria treponema palladium.</p>
<p>Types</p>
<ol>
<li>Congenital syphilis</li>
<li>Acquired syphilis</li>
</ol>
<p>Congenital syphilis</p>
<p>A pregnant mother can transmit palladium to the foetus through the placenta beginning from 10 weeks gestation.</p>
<p>Intrauterine foetal complications include; Death, miscarriages and still born.</p>
<p>After birth complications; some children develop signs of congenital syphilis in early childhood which include: interstitial keratitis, Hutchinson teeth, saddle nose and periostitis.</p>
<p>Acquired syphilis</p>
<p>54</p>
<p>T. palladium is inoculated into the tissues through a small abrasion usually as a result of sexual contact.</p>
<ol>
<li>
<p>Primary stage: Initial lesion consisting of a painless, hard, red papule at the site of inoculation which later ruptures and forms an ulcer on the penis and cervix or vulva (chancre). The lesion diapers with evidence of scars. Lymphadenopathy of the neighboring lymph glands.</p>
</li>
<li>
<p>Secondary stage: 6 weeks after infection and prolonged to 2 years. Secondary lesions regress involving the oropharynx and diaper with evidence of scars. The patient is highly infectious during this stage.</p>
</li>
</ol>
<p>Signs and symptoms in this stage include: headaches, swollen lymph nodes, fatigue, fever, weight loss, hair loss and aching joints.</p>
<ol start="3">
<li>Tertiary stage: the lesions appear 2-15 years after infection.</li>
</ol>
<p>Skin and mucous membrane- ulcers in the legs, palate, face or tongue.</p>
<p>Cardiovascular system- diseases of aortic valve or the walls of blood vessels leading to aneurysm.</p>
<p>Bones and periosteum- osteitis and periostitis</p>
<p>Central nervous system</p>
<p>Signs and symptoms include: blindness, deafness, mental illness, memory loss, destruction of soft tissue and bone, neurological disorders, such as stroke or meningitis, heart disease and neurosyphilis, which is an infection of the brain or spinal cord</p>
<p>Diagnosis</p>
<p>Serological test; VDRL and rapid diagnostic test (RDT).</p>
<p>Treatment</p>
<p>Antibiotics: Tetracycline, Doxycycline, azithromycin, ceftriaxone injection, penicillin injection.</p>
<p>Gonorrhea</p>
<p>55</p>
<p>It is the most prevalent of the notifiable communicable diseases which is characterized by infection of the mucous membrane by a parasite Neisseria gonorrhea (gonococcus).</p>
<p>It may occur in both sexes and newborn. It causes a surface infection affecting the urethra, ascending in almost all the cases by way of the lower genital tract. Incubation period 3-10 days.</p>
<p>Signs and symptoms</p>
<ul>
<li>Urinary frequency</li>
<li>Dysuria</li>
<li>Yellowish discharge from the vagina, anus or urethra</li>
<li>Salpingitis (tubal infection)</li>
<li>Lower abdominal pain and back pain which is aggravated by defecation, dysmenorrhea or menorrhagia.</li>
</ul>
<p>Diagnosis</p>
<ul>
<li>Pus swab smear stained by gram's stain</li>
<li>Pus swab for culture</li>
</ul>
<p>Treatment</p>
<ul>
<li>Ceftriaxone injection of oral azithromycin, or doxycycline.</li>
</ul>
<p>Chancroid
Also called "soft chancre" and "ulcer molle". It is an acute, localized, auto inoculable infection of the genitals caused by bacteria streptobacillus of Ducrey (Haemophilus Ducrey). Incubation period 1-5 days but it can last up to 30 days.</p>
<p>Signs and symptoms</p>
<ul>
<li>Ulcer have a soft center that is gray to yellowish-gray with defined, or sharp, edges, the ulcers may bleed easily if touched.</li>
<li>Pain during sex or urination</li>
</ul>
<p>56</p>
<p>Swollen lymph nodes</p>
<p>Types</p>
<ol>
<li>Follicular chancroid- Originates in the hair follicles seen on the vulva and on the hair surface round the genitalia, very superficial.</li>
<li>Dwarf chancroid- Small lesions</li>
<li>Transient chancroid- Small lesions typical chancroidal type.</li>
<li>Giant chancroid- May start as a small ulcer but extends rapidly and covers a considerable area.</li>
<li>Popular chancroid- Starts as an ulcer but later becomes raised particularly around its edges.</li>
<li>Phagedenic chancroid- May commence as small lesion but becomes large and destructive with widespread necrosis of tissues. External genitalia may be destroyed.</li>
</ol>
<p>Diagnosis</p>
<p>Fluid swab for smear by gram’s stain- it is a gram negative bacteria.</p>
<p>Fluid swab for culture and microscopy.</p>
<p>Treatment</p>
<p>Antibiotics: azithromycin, ceftriaxone, ciprofloxacin and erythromycin.</p>
<p>Chlamydia</p>
<p>It is a sexually transmitted infection caused by a bacteria Chlamydia trachomatis. It is spread through anal, vaginal or oral sex. It is usually asymptomatic but if symptoms occur, they include;</p>
<ul>
<li>Pain or discomfort during sex or urination</li>
<li>Green or yellow discharge from the penis, anus or vagina</li>
<li>Lower abdominal pain.</li>
</ul>
<p>If left untreated, chlamydia can lead to; infections of the urethra, prostate gland, or testicles, pelvic inflammatory disease and infertility.</p>
<p>57</p>
<p>Newborn babies can acquire chlamydia from their mother during birth. Complication to the baby after birth: Pneumonia, Eye infections and Blindness.</p>
<p>Diagnosis</p>
<p>Vaginal swab in female and urine test is men</p>
<p>Treatment</p>
<p>Antibiotics: Doxycycline 500mg twice a day for 7 days.</p>
<p>Candidiasis</p>
<p>Candidiasis is a fungal infection caused by a yeast type of fungus called Candida. Candida normally lives inside the body (in places such as the mouth, throat, gut, and vagina) and on skin without causing any problems. Sometimes Candida can multiply and cause an infection if the environment inside the vagina changes in a way that encourages its growth. Candidiasis in the vagina is commonly called a "vaginal yeast infection." Other names for this infection are "vaginal candidiasis," "vulvovaginal candidiasis," or "candidal vaginitis" causes by candida albicans.</p>
<p>Signs and symptoms</p>
<ul>
<li>Vaginal itching or soreness</li>
<li>Pain during sexual intercourse</li>
<li>Pain or discomfort when urinating</li>
<li>Abnormal vaginal discharge (a heavy, curdy, white)</li>
</ul>
<p>Diagnosis</p>
<p>Physical examination</p>
<p>Vaginal swab for microscopy</p>
<p>Treatment</p>
<p>Antifungal medications- Fluconazole, nystatin oral drops</p>
<p>58</p>
<p>Topical antifungal-</p>
<p>Genital and anal warts</p>
<p>Genital warts a sexually transmitted infection caused by certain low-risk strains of the human papillomavirus (HPV). These are different from the high-risk strains that can lead to cervical dysplasia and cancer. Genital warts are soft growths that appear on the genitals. They can cause pain, discomfort, and itching.</p>
<p>Signs and symptoms</p>
<p>The growths may resemble a cauliflower and may feel smooth or slightly bumpy to the touch. They may occur as a cluster of warts, or just one wart. The growths will appear on the penis, scrotum, groin, thighs, inside or around the anus, inside of the vagina or on the cervix.</p>
<p>Diagnosis</p>
<p>Physical examination</p>
<p>Treatment</p>
<ul>
<li>Topical wart treatment</li>
<li>Surgery</li>
</ul>
<p>Herpes simplex virus (HSV)</p>
<p>This is a sexually transmitted infection that causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid.</p>
<p>HSV-1 causes oral herpes passed through oral sex.</p>
<p>HSV-2 causes genital herpes passed through vaginal or anal sex.</p>
<p>Signs and symptoms</p>
<p>The blistery sores develop around the mouth, anus, buttocks, scrotum, penis and vagina.</p>
<p>59</p>
<p>Congenital herpes is very dangerous and it can lead to ulcers of the face, body and genitalia.
Complications include: blindness, brain damage and death.</p>
<p>Diagnosis</p>
<p>Blood test</p>
<p>Treatment</p>
<p>Antiviral medications. Treatment reduces outbreak and transmission but does not cure the virus.</p>
<p>HIV/AIDS</p>
<p>Association between HIV/AIDS and STIs: Present of past history of STI is among the major risk factors for HIV transmission</p>
<p>6.6: Syndromic management of STIS</p>
<p>Syndrome: Genital ulcer disease (GUD)</p>
<p>Signs and symptoms: Genital sore and genital ulcers</p>
<p>Common cause:</p>
<ul>
<li>Chancroid</li>
<li>Genital herpes</li>
<li>Syphilis</li>
</ul>
<p>Syndrome: Urethral discharge and urethritis</p>
<p>Signs and symptoms:</p>
<ul>
<li>Dysuria (pain during urination)</li>
<li>Frequent urination</li>
<li>Urethral discharge, (if necessary, ask the patient to milk the urethra)</li>
</ul>
<p>60</p>
<p>Common causes:</p>
<ul>
<li>Chlamydia</li>
<li>Gonorrhea</li>
</ul>
<p>Syndrome: Vaginal discharge and Vaginitis</p>
<p>Signs and symptoms:</p>
<ul>
<li>Dyspareunia (pain during sexual intercourse)</li>
<li>Dysuria (pain during urination)</li>
<li>Unusual vaginal discharge</li>
<li>Vaginal itching</li>
<li>Abnormal vaginal discharge</li>
</ul>
<p>Common cause:</p>
<ul>
<li>Candidiasis</li>
<li>Chlamydia</li>
<li>Gonorrhea</li>
</ul>
<p>Syndrome: Genital and anal warts</p>
<p>Common cause: Human papilloma virus</p>
<p>Management</p>
<p>In the Syndromic management, treatment of a patient with above syndromes should adequately cover all these STIs. Where reliable laboratory facilities are available, a distinction can be made between the two organisms and specific treatment instituted. Persistent or recurrent symptoms may result from drug resistance, poor compliance with the treatment or reinfection. Where symptoms persist or recur after adequate treatment in the patient and his/her partner(s), the patient should be treated for other STIs.</p>
<p>6.7: Importance of adherence
Compliance with the treatment is very key in order to prevent drug resistance</p>
<p>6.8: Association between HIV, AIDS &amp; STIs
STIs are the great risk factors for HIV</p>
<p>61</p>
<p>6.9: Effects/impacts of HIV</p>
<ul>
<li>HIV/AIDS affects the physical, emotional, moral, and economic well-being of the individual, family, community, nation, and the global community.</li>
<li>The HIV/AIDS pandemic is a serious threat to the health of all regardless of age, sex, social status, or race.</li>
<li>Individuals diagnosed with HIV experience profound psychosocial effects, particularly interactions with others while the major burden of caring for PLWHA rests with the family.</li>
<li>Most of HIV-positive individuals are lonely, and often have to cope with stigmatization and suffer disruption of family and peer relationship.</li>
<li>They also suffer from prolonged uncertainty about their lives and experience intense fear of disclosure of their illness.</li>
<li>Stigmatization worsens this impact because it hinders the prevention and treatment of HIV and hampers social support and HIV disclosure.</li>
<li>HIV positive individuals are faced with discrimination and inequality in matters of securing and sustaining employment, and vital services such as life assurance.</li>
<li>The families of the infected individuals experience secondary stigmatization and face financial constraints to care for the affected individuals.</li>
<li>Families experience death and incapacity of loved ones and have to cope.</li>
</ul>
<p>62</p>
<p>63</p>
<p>Teaching/Learning Strategies</p>
<p>Modified/Interactive lectures, small group discussion, group work, demonstrations, self-directed learning, group assignment/presentation, individual assignment/presentation.</p>
<p>Teaching/Learning Resources</p>
<p>Flip Charts, black board, chalk, white board, marker pens, masking tape, note books and pens, power point, LCD projector, laptops, print handout, television, desk top computer mobile phones.</p>
<p>Assessment Strategies;</p>
<ol>
<li>Formative: CATS, RATs, assignments, tests, ESE</li>
<li>Summative: Practicum reports, dissertation, projects, posters, audios, flip charts, booklets, FQE.</li>
</ol>
<p>References/Further Readings</p>
<ol>
<li>New Kenya art guidelines July 2016</li>
<li>New ART guidelines July 2016</li>
<li>National policy on HIV pre-exposure prophylaxis 2017</li>
<li>National HIV testing services policy and guidelines 2016</li>
<li>Kenya nutrition and HIV/AIDS strategy 2007-2010</li>
<li>Framework for the implementation of pre-exposure prophylaxis of HIV in Kenya 2017-2022.</li>
</ol></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>